ES2180648T3 - Paraoxonasa serica. - Google Patents
Paraoxonasa serica.Info
- Publication number
- ES2180648T3 ES2180648T3 ES95925340T ES95925340T ES2180648T3 ES 2180648 T3 ES2180648 T3 ES 2180648T3 ES 95925340 T ES95925340 T ES 95925340T ES 95925340 T ES95925340 T ES 95925340T ES 2180648 T3 ES2180648 T3 ES 2180648T3
- Authority
- ES
- Spain
- Prior art keywords
- polypeptide
- disclosed
- present
- paroxonase
- serica
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
SE PRESENTAN UNA ENZIMA DE PARAOXONASA DEL SUERO HUMANO Y UN ADN (ARN) QUE CODIFICA TALES ENZIMAS DE PARAOXONASA DEL SUERO. TAMBIEN SE PRESENTA EL PROCEDIMIENTO PARA LA PRODUCCION DE TALES POLIPEPTIDOS MEDIANTE TECNICAS RECOMBINANTES. LOS USOS DE TALES POLIPEPTIDOS INCLUYEN SU USO COMO ANTIDOTO CONTRA EL ENVENENAMIENTO DE ORGANOFOSFATOS Y PARA PREVENIR LA MUERTE DE CELULAS NEURONALES. TAMBIEN SE PRESENTAN ENSAYOS DE DIAGNOSTICO PARA IDENTIFICAR LAS MUTACIONES EN UNA SECUENCIA DE ACIDOS NUCLEICOS QUE CODIFICA UN POLIPEPTIDO DE LA PRESENTE INVENCION Y PARA DETECTAR LOS NIVELES ALTERADOS DEL POLIPEPTIDO DE LA PRESENTE INVENCION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/270,583 US5629193A (en) | 1994-07-05 | 1994-07-05 | Paraoxonase |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2180648T3 true ES2180648T3 (es) | 2003-02-16 |
Family
ID=23031914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95925340T Expired - Lifetime ES2180648T3 (es) | 1994-07-05 | 1995-06-28 | Paraoxonasa serica. |
Country Status (13)
Country | Link |
---|---|
US (4) | US5629193A (es) |
EP (2) | EP0804591B1 (es) |
JP (2) | JPH10502255A (es) |
KR (1) | KR970704887A (es) |
CN (1) | CN1151760A (es) |
AT (1) | ATE224953T1 (es) |
CA (1) | CA2194390A1 (es) |
DE (1) | DE69528379T2 (es) |
DK (1) | DK0804591T3 (es) |
ES (1) | ES2180648T3 (es) |
NZ (1) | NZ289607A (es) |
PT (1) | PT804591E (es) |
WO (1) | WO1996001322A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5629193A (en) | 1994-07-05 | 1997-05-13 | Human Genome Sciences, Inc. | Paraoxonase |
GB9511412D0 (en) * | 1995-06-06 | 1995-08-02 | Johnson Matthey Plc | Improvements in emission control |
US7541519B2 (en) * | 1995-12-14 | 2009-06-02 | Cargill, Incorporated | Fatty acid desaturases and mutant sequences thereof |
DE69822164T2 (de) * | 1997-06-30 | 2005-04-14 | Glaxo Group Ltd., Greenford | Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität |
US6414223B1 (en) * | 1998-08-03 | 2002-07-02 | Cargill, Incorporated | Plants, seeds and oils having an elevated total monounsaturated fatty acid content |
US6391298B1 (en) | 1998-11-25 | 2002-05-21 | Bayer Corporation | Method of using PON-1 to decrease atheroma formation |
JP2000333674A (ja) * | 1999-05-24 | 2000-12-05 | Bml Inc | パラオキソナーゼに対するモノクローナル抗体及びこれを用いる動脈硬化の判定方法 |
US6573370B1 (en) | 2000-05-19 | 2003-06-03 | Regents Of The University Of Michigan | PON3 and uses thereof |
US20020151068A1 (en) * | 2001-01-03 | 2002-10-17 | Board Of Regents, The University Of Texas System | Compositions and methods for the diagnosis and treatment of organophosphate toxicity |
CN1854300B (zh) * | 2005-04-29 | 2013-04-17 | 中国人民解放军军事医学科学院毒物药物研究所 | 含pon基因的重组质粒及其应用 |
JP2011503517A (ja) * | 2006-11-13 | 2011-01-27 | アテリス テクノロジーズ,エルエルシー | 農薬バイオマーカー |
CA2719103A1 (en) * | 2007-11-14 | 2009-05-22 | Ateris Technologies, Llc | Biomarker detection |
WO2013040501A1 (en) | 2011-09-16 | 2013-03-21 | Pharmathene, Inc. | Compositions and combinations of organophosphorus bioscavengers and hyaluronan-degrading enzymes, and uses thereof |
CN108196064A (zh) * | 2017-12-26 | 2018-06-22 | 黑龙江八农垦大学 | 一种牛pon1蛋白的双抗夹心elisa检测试剂盒及检测方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260203A (en) * | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5629193A (en) | 1994-07-05 | 1997-05-13 | Human Genome Sciences, Inc. | Paraoxonase |
-
1994
- 1994-07-05 US US08/270,583 patent/US5629193A/en not_active Expired - Lifetime
-
1995
- 1995-06-28 EP EP95925340A patent/EP0804591B1/en not_active Expired - Lifetime
- 1995-06-28 ES ES95925340T patent/ES2180648T3/es not_active Expired - Lifetime
- 1995-06-28 PT PT95925340T patent/PT804591E/pt unknown
- 1995-06-28 DK DK95925340T patent/DK0804591T3/da active
- 1995-06-28 CN CN95193978A patent/CN1151760A/zh active Pending
- 1995-06-28 WO PCT/US1995/008111 patent/WO1996001322A1/en active IP Right Grant
- 1995-06-28 DE DE69528379T patent/DE69528379T2/de not_active Expired - Fee Related
- 1995-06-28 AT AT95925340T patent/ATE224953T1/de not_active IP Right Cessation
- 1995-06-28 JP JP8503904A patent/JPH10502255A/ja not_active Ceased
- 1995-06-28 EP EP02000397A patent/EP1217007A2/en not_active Withdrawn
- 1995-06-28 NZ NZ289607A patent/NZ289607A/xx not_active IP Right Cessation
- 1995-06-28 CA CA002194390A patent/CA2194390A1/en not_active Abandoned
- 1995-06-28 KR KR1019970700009A patent/KR970704887A/ko not_active Application Discontinuation
-
1997
- 1997-01-16 US US08/783,889 patent/US5792639A/en not_active Expired - Fee Related
-
1998
- 1998-04-27 US US09/067,089 patent/US6140093A/en not_active Expired - Fee Related
-
2002
- 2002-06-27 JP JP2002187866A patent/JP2003088364A/ja active Pending
-
2004
- 2004-09-02 US US10/932,269 patent/US7026140B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0804591B1 (en) | 2002-09-25 |
US7026140B2 (en) | 2006-04-11 |
EP1217007A2 (en) | 2002-06-26 |
NZ289607A (en) | 1998-11-25 |
EP0804591A1 (en) | 1997-11-05 |
DE69528379T2 (de) | 2003-06-12 |
US20050026226A1 (en) | 2005-02-03 |
US6140093A (en) | 2000-10-31 |
CA2194390A1 (en) | 1996-01-18 |
US5792639A (en) | 1998-08-11 |
PT804591E (pt) | 2002-12-31 |
JPH10502255A (ja) | 1998-03-03 |
DK0804591T3 (da) | 2003-01-20 |
US5629193A (en) | 1997-05-13 |
DE69528379D1 (de) | 2002-10-31 |
JP2003088364A (ja) | 2003-03-25 |
KR970704887A (ko) | 1997-09-06 |
WO1996001322A1 (en) | 1996-01-18 |
CN1151760A (zh) | 1997-06-11 |
AU704834B2 (en) | 1999-05-06 |
ATE224953T1 (de) | 2002-10-15 |
AU2950795A (en) | 1996-01-25 |
EP0804591A4 (en) | 1998-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2180648T3 (es) | Paraoxonasa serica. | |
EP1757689A3 (en) | Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods | |
Summaria et al. | Isolation and characterization of the affinity chromatography forms of human Glu-and Lys-plasminogens and plasmins. | |
DE69635864D1 (de) | Rekombinante rna-replikase von hepatitis-c-virus | |
Castellino | A unique enzyme—protein substrate modifier reaction: plasmin/streptokinase interaction | |
CY1107629T1 (el) | Πρωτεïνη crsp (πλουσιες σε κυστεïνη εκκρινομενες πρωτεïνες) μορια νουκλεϊνικου οξεως που τις κωδικοποιουν και χρησεις τους | |
NZ323795A (en) | Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides | |
Rodriguez et al. | Modification of the C-terminus of brain tubulin during development | |
ATE523593T1 (de) | Membranproteine aus säugetierzellen und verwandte reagentien | |
WO2000020446A3 (en) | Bax-mediated apoptosis modulating reagents and methods | |
Brevet et al. | Comparative structural analysis of myosin after limited tryptic hydrolysis by use of two-dimensional gel electrophoresis | |
EP0395653A4 (en) | Synovial phospholipases | |
Anderson et al. | LDHk, a uniquely regulated cryptic lactate dehydrogenase associated with transformation by the Kirsten sarcoma virus. | |
WO1997035976A3 (en) | Epidermal differentiation factor | |
MX9700149A (es) | Seroparaoxonasa. | |
DE69735562D1 (de) | Sonden zur Erkennung und Identifizierung von Helicobacter Pylori | |
Boschetti et al. | The membrane anchor of mammalian brain acetylcholinesterase consists of a single glycosylated protein of 22 kDa | |
EP0841399A3 (en) | Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor | |
Miyanishi et al. | Differences in chemical structure around the reactive lysine residues in the burst and the nonburst heads of skeletal muscle myosin | |
Finel | Studies on the oligomeric state of isolated cytochrome oxidase using cross-linking reagents | |
EP0330358A3 (en) | Method of identifying whole cells having serine esterase activity | |
Kageoka et al. | Amino acid substitution and chemical characterization of a Japanese variant of carbonic anhydrase I: CA I Hiroshima-1 (86 Asp→ Gly) | |
Oppenheim et al. | A modified procedure for the purification of clostridial collagenase | |
EP0837127A3 (en) | Hereditary multiple exostose gene, Ext2 | |
NO971359L (no) | Humant galaktokinase-gen |